Roche Discontinues Huntington’s Gene-Silencing Program Amid Competitive Pressures
Roche has discontinued its Huntington's disease gene-silencing program, highlighting competitive pressures in neurodegenerative therapeutics. The decision comes as ARPA-H launches…
Editor's Top Picks
Federal Health Nominee’s Past Vaccine Safety Statements Under Senate Scrutiny
Sean Kaufman, nominated for a key federal health position, faces Senate scrutiny over past statements questioning vaccine safety. Senator Bill…
Submit Your Paper to GMJ
Aging Muscle’s Double Bind: How a Protective Protein Slows Healing in Older Adults
UCLA researchers discovered that NDRG1 protein accumulation in aging muscle stem cells slows repair responses to injury, yet protects cells…
Heart Palpitations: When Skipped Beats Signal a Clinical Concern
Heart palpitations affect 16% of adults presenting to primary care but rarely indicate serious disease. Systematic clinical assessment, 12-lead ECG,…
Health Insurer Elevance Challenges CMS Over $115 Million Medicare Advantage Star Rating Dispute
Elevance Health has filed suit against the Centers for Medicare & Medicaid Services over disputed Medicare Advantage star rating calculations,…
Australia Tightens Social Media Enforcement With $99 Million Penalties as First-Year Ban Shows Mixed Results
Australia has escalated enforcement of its year-old social media ban for under-16s by raising maximum penalties to A$99 million and…
Protein ‘Mitch’ emerges as potential obesity treatment target in human cell study
Researchers have identified a protein called Mitch that, when disabled in human cells, enhances fat metabolism and suppresses new fat…
UNICEF warns of devastating toll on children in armed conflict zones across globe
UNICEF Executive Director Catherine Russell warned the UN Security Council that children in armed conflict zones face a cascading health…
CAR T cell therapy targets mutant calreticulin in myelofibrosis: new hope for precision cancer immunotherapy
A new CAR T cell therapy engineered to target mutant calreticulin successfully depleted disease-driving cells in myelofibrosis xenografts and human…
Correction issued for GDP-mannose immunotherapy study in triple-negative breast cancer
Science Translational Medicine has issued a formal erratum for a July 2026 research article on guanosine diphosphate–mannose as a potential…